Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4861486
Max Phase: Preclinical
Molecular Formula: C23H24N8
Molecular Weight: 412.50
Molecule Type: Unknown
Associated Items:
ID: ALA4861486
Max Phase: Preclinical
Molecular Formula: C23H24N8
Molecular Weight: 412.50
Molecule Type: Unknown
Associated Items:
Canonical SMILES: N#Cc1c(N2CCNCC2)c2ccc(N3CCNCC3)cc2n2c1nc1ncccc12
Standard InChI: InChI=1S/C23H24N8/c24-15-18-21(30-12-8-26-9-13-30)17-4-3-16(29-10-6-25-7-11-29)14-20(17)31-19-2-1-5-27-22(19)28-23(18)31/h1-5,14,25-26H,6-13H2
Standard InChI Key: UAUOUUMIFKJDMO-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 412.50 | Molecular Weight (Monoisotopic): 412.2124 | AlogP: 1.73 | #Rotatable Bonds: 2 |
Polar Surface Area: 84.52 | Molecular Species: BASE | HBA: 8 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.11 | CX LogP: 1.29 | CX LogD: -1.55 |
Aromatic Rings: 4 | Heavy Atoms: 31 | QED Weighted: 0.52 | Np Likeness Score: -1.02 |
1. Lončar B, Perin N, Mioč M, Boček I, Grgić L, Kralj M, Tomić S, Stojković MR, Hranjec M.. (2021) Novel amino substituted tetracyclic imidazo[4,5-b]pyridine derivatives: Design, synthesis, antiproliferative activity and DNA/RNA binding study., 217 [PMID:33751978] [10.1016/j.ejmech.2021.113342] |
Source(1):